Abbvie
Precision Medicine - Clinical Biomarker Lead, Immuno-Oncology
Fate Therapeutics Inc 2017 - Jul 2018
Senior Scientist - Translational Research and Genome Biology
Millennium Health Dec 1, 2014 - Jul 2017
Senior Research Development Scientist
Invivoscribe 2014 - 2014
Development Scientist
University of Chicago 2012 - 2014
Clinical Pharmacology and Pharmacogenomics Fellow
Education:
University of Chicago 2012 - 2014
University of Southern California 2006 - 2012
Doctorates, Doctor of Philosophy, Pharmacology
Zhejiang University 2001 - 2005
Bachelors, Bachelor of Pharmacy, Pharmacy
The University of Hong Kong 2003 - 2004
Hangzhou No.2 Middle School 1998 - 2001
Skills:
Molecular Biology Cancer Assay Development In Vivo Pharmacology Western Blotting Sequencing Cell Biology Elisa Cell Drug Discovery Translational Medicine Pcr In Vitro Cell Culture Genomics Facs Analysis Ngs Cancer Research Clinical Pharmacology Dna Dna Sequencing Qpcr Molecular Pharmacology Apoptosis Subcloning Elispot Snp Genotyping Pharmacogenetics Clinical Development Protein Expression Biomarkers Immunofluorescence Transfection Oncology Immunohistochemistry Translational Research Clinical Trials Rt Pcr Confocal Microscopy Protein Chemistry Vaccines Clinical Research Fluorescence Microscopy Cell Signaling Biomarker Discovery Pre Clinical Mouse Models Cancer Biology Sanger Sequencing Immunoge
Languages:
Mandarin English
Certifications:
Translational Cancer Research For Basic Scientist Workshop Clinical Pharmacology and Pharmacogenomics Fellowship Introduction To Genomic Technologies By Johns Hopkins University on Coursera. Aacr University of Chicago Medicine
Hua Fang - San Jose CA, US John Chen - Cupertino CA, US
Assignee:
PDF Solutions, Inc. - San Jose
International Classification:
G11C 29/44 G11C 29/50
US Classification:
714718, 714741
Abstract:
A method for predicting an impact on post-repair yield resulting from manufacturing process modification is described. The method includes receiving bit data representing locations of defective memory cells for a plurality of memory devices. The bit data is modified by removing a selected failure pattern type according to a modification scheme to generate modified bit data. Repairs are simulated on hypothetical memory devices corresponding to the modified bit data, generating a result indicating whether the hypothetical memory device is good or bad. A post-repair yield is then identified and a report is generated indicating the post-repair yield, the post-repair yield representing a number of the plurality of memory devices that would be functional after repair had the plurality of memory devices been manufactured without the selected failure pattern. A method to identify a process providing the best economic benefit is also described.
Youtube
(Huafang Guniang) - (Cuijian)
Cui Jian 92 Live at Beijing for Cancer Foundation.
Duration:
7m 1s
Hua Fang Gu Niang __Cui Jian 2020.06.18.
The best ever version of this legendary song, so far.
Duration:
6m 57s
Feng Ming JJ - Fang Hua Man [Chinese Song]
Subscribe and ceck for more chinese song.
Duration:
3m 29s
Huafang Technology Product
We focus on the field of textile machinery manufacturing, committed to...
Duration:
9m 34s
- "hua fang gu niang" (Greenhouse Girl) Lyri...
Song title : Sing... : .
Duration:
4m 1s
2018 Falling Dreams of Fang Hua (Novel Traile...
Used as part of a 2018 April Fools prank for volarenovels (along with ...